NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

合法大麻的全球市場

Legal Marijuana

出版商 Global Industry Analysts, Inc. 商品編碼 997495
出版日期 內容資訊 英文 146 Pages
商品交期: 最快1-2個工作天內
價格
合法大麻的全球市場 Legal Marijuana
出版日期: 2021年04月01日內容資訊: 英文 146 Pages
簡介

全球合法大麻的市場規模,預計在分析期間(2020年∼2027年)將以20.9%的年複合成長率增長,從2020年的242億美元,到2027年達到912億美元。

本報告所分析的市場區隔之一的醫療用大麻部門,在分析期間中預計將以20.6%的年複合成長率增長,達到690億美元。

本報告提供全球合法大麻市場的相關調查,提供市場佔有率,Covid-19的影響,趨勢和成長要素,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

調查對象企業範例

  • Aphria Inc.
  • Aurora Cannabis, Inc.
  • Beacon Medical
  • Canopy Growth Corporation
  • Cronos Group
  • OrganiGram Holdings, Inc.
  • Tikun Olam Ltd.
  • Tilray, Inc.
  • Wayland Group Corporation

目錄

I. 調查手法

II. 摘要整理

  • 市場概要
    • 影響者市場洞察
    • 全球市場的軌跡
    • Covid-19的影響與即將到來的全球景氣衰退
  • 主要企業
  • 趨勢與推動要素
  • 全球市場預測

III. 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 其他地區

IV. 競爭

  • 企業簡介:46公司

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP12993

Abstract:

Global Legal Marijuana Market to Reach $91.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Legal Marijuana estimated at US$24.2 Billion in the year 2020, is projected to reach a revised size of US$91.2 Billion by 2027, growing at aCAGR of 20.9% over the period 2020-2027. Medical Marijuana, one of the segments analyzed in the report, is projected to record 20.6% CAGR and reach US$69 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Recreational Marijuana segment is readjusted to a revised 21.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $7.2 Billion, While China is Forecast to Grow at 20.1% CAGR

The Legal Marijuana market in the U.S. is estimated at US$7.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$15.6 Billion by the year 2027 trailing a CAGR of 20.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.7% and 18.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 15.4% CAGR.

Select Competitors (Total 46 Featured) -

  • Aphria Inc.
  • Aurora Cannabis, Inc.
  • Beacon Medical
  • Canopy Growth Corporation
  • Cronos Group
  • OrganiGram Holdings, Inc.
  • Tikun Olam Ltd.
  • Tilray, Inc.
  • Wayland Group Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Legal Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World 7-Year Perspective for Legal Marijuana by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
    • TABLE 3: World Current & Future Analysis for Medical Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 4: World 7-Year Perspective for Medical Marijuana by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 5: World Current & Future Analysis for Recreational Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 6: World 7-Year Perspective for Recreational Marijuana by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World 7-Year Perspective for Chronic Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 9: World Current & Future Analysis for Mental Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 10: World 7-Year Perspective for Mental Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 11: World Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 12: World 7-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 15: USA Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 16: USA 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 17: USA Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 18: USA 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • CANADA
    • TABLE 19: Canada Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 20: Canada 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 21: Canada Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 22: Canada 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • JAPAN
    • TABLE 23: Japan Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 24: Japan 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 25: Japan Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: Japan 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • CHINA
    • TABLE 27: China Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 28: China 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 29: China Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 30: China 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • EUROPE
    • TABLE 31: Europe Current & Future Analysis for Legal Marijuana by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 32: Europe 7-Year Perspective for Legal Marijuana by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
    • TABLE 33: Europe Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 34: Europe 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 35: Europe Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 36: Europe 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • FRANCE
    • TABLE 37: France Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: France 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 39: France Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 40: France 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • GERMANY
    • TABLE 41: Germany Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 42: Germany 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 43: Germany Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Germany 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • ITALY
    • TABLE 45: Italy Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 46: Italy 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 47: Italy Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 48: Italy 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • UNITED KINGDOM
    • TABLE 49: UK Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: UK 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 51: UK Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 52: UK 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 54: Rest of Europe 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 55: Rest of Europe Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Rest of Europe 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 57: Asia-Pacific Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 58: Asia-Pacific 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 59: Asia-Pacific Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 60: Asia-Pacific 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • REST OF WORLD
    • TABLE 61: Rest of World Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Rest of World 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 63: Rest of World Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 64: Rest of World 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 46